Skip to content

Clinical trials

Recruiting Cardiomyopathies trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Status: Recruiting Country / region: Italy Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20181
20211
20236
20241
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IRCCS Azienda Ospedaliero-Universitaria di Bologna3
Rocket Pharmaceuticals Inc.2
Scientific Institute San Raffaele2
Alnylam Pharmaceuticals1
Bayer1
Eidos Therapeutics, a BridgeBio company1
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Intellia Therapeutics1
Lexeo Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies16
Heart Failure5
Amyloid Neuropathies, Familial4
Amyloidosis3
Arrhythmias, Cardiac3
Myocarditis3
Autoimmune Diseases2
Cardiomyopathy, Dilated2
Cardiomyopathy, Hypertrophic2
Genetic Predisposition to Disease2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.